Targets for botulinum toxin in the lower urinary tract

Botulinum Toxin A Detrusor Injections Reduce Postsynaptic Muscular M2, M3, P2X2, and P2X3 Receptors in Children and Adolescents Who Have Neurogenic Detrusor Overactivity: A Single-blind Study

(2013) Heinrich Schulte-Baukloh et al.   UROLOGY

Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder

(2012) Youko Ikeda et al.   EUROPEAN UROLOGY

Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action

(2012) Ana Coelho et al.   EUROPEAN UROLOGY

997 Urinary levels of noradrenaline are increased in patients with bladder pain syndrome/interstitial cystitis and are decreased by intratrigonal onabotulinum toxin type A injection

(2012) R.M.C.A. Pinto et al.   EUROPEAN UROLOGY SUPPLEMENTS

Effect of OnabotulinumtoxinA on Intramural Parasympathetic Ganglia: An Experimental Study in the Guinea Pig Bladder

(2012) Ana Coelho et al.   JOURNAL OF UROLOGY

Persistent Therapeutic Effect of Repeated Injections of Onabotulinum Toxin A in Refractory Bladder Pain Syndrome/Interstitial Cystitis

(2012) Rui Pinto et al.   JOURNAL OF UROLOGY

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

(2012) Victor W. Nitti et al.   JOURNAL OF UROLOGY

Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay

(2012) Ester Fernández-Salas et al.   PLoS One

Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection

(2012) Tiago Gorgal et al.   BMC Urology

Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial

(2011) Francisco Cruz et al.   EUROPEAN UROLOGY

Contemporary Management of the Painful Bladder: A Systematic Review

(2011) Antonella Giannantoni et al.   EUROPEAN UROLOGY

Effects of 100 and 300 Units of Onabotulinum Toxin A on Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Phase II Randomized Clinical Trial

(2011) E. David Crawford et al.   JOURNAL OF UROLOGY

Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function

(2010) João Silva et al.   BJU INTERNATIONAL

Trigonal Injection of Botulinum Toxin A in Patients with Refractory Bladder Pain Syndrome/Interstitial Cystitis

(2010) Rui Pinto et al.   EUROPEAN UROLOGY

Immunohistochemical Expression of Muscarinic Receptors in the Urothelium and Suburothelium of Neurogenic and Idiopathic Overactive Human Bladders, and Changes With Botulinum Neurotoxin Administration

(2010) Soumendra N. Datta et al.   JOURNAL OF UROLOGY

Subcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia

(2010) Lizu Xiao et al.   PAIN MEDICINE

Intravesical Electromotive Botulinum Toxin Type A Administration—Part II: Clinical Application

(2010) Abdol-Mohammad Kajbafzadeh et al.   UROLOGY

Lack of effectiveness of botulinum neurotoxin A on isolated detrusor strips and whole bladders from mice and guinea-pigsin vitro

(2009) Sarah Howles et al.   BJU INTERNATIONAL

Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome

(2009) Hann-Chorng Kuo et al.   BJU INTERNATIONAL

In the Human Urothelium and Suburothelium, Intradetrusor Botulinum Neurotoxin Type A Does Not Induce Apoptosis: Preliminary Results

(2009) Thomas M. Kessler et al.   EUROPEAN UROLOGY

Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder

(2009) Ana Coelho et al.   EUROPEAN UROLOGY

Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Liposomes

(2009) Yao-Chi Chuang et al.   JOURNAL OF UROLOGY

Interstitial cells in the urinary bladder—localization and function

(2009) Karen D. McCloskey   NEUROUROLOGY AND URODYNAMICS

A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging

(2009) Ulrich Mehnert et al.   WORLD JOURNAL OF UROLOGY

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

(2008) Alexander Roosen et al.   EUROPEAN UROLOGY

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

(2008) Hsin-Tzu Liu et al.   EUROPEAN UROLOGY

Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report

(2008) Apostolos Apostolidis et al.   EUROPEAN UROLOGY

Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat

(2008) João Silva et al.   EUROPEAN UROLOGY

Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury

(2007) Christopher P. Smith et al.   NEUROCHEMISTRY INTERNATIONAL